TY - JOUR
T1 - Image-guided interventional therapy for cancer with radiotherapeutic nanoparticles
AU - Phillips, William T.
AU - Bao, Ande
AU - Brenner, Andrew J.
AU - Goins, Beth A.
N1 - Funding Information:
This research was supported in part by NIH grants 5 P30 CA054174-16 and R01 CA131039 . The authors also appreciate Jonathan Sumner for his help in figure preparation.
PY - 2014
Y1 - 2014
N2 - One of the major limitations of current cancer therapy is the inability to deliver tumoricidal agents throughout the entire tumor mass using traditional intravenous administration. Nanoparticles carrying beta-emitting therapeutic radionuclides that are delivered using advanced image-guidance have significant potential to improve solid tumor therapy. The use of image-guidance in combination with nanoparticle carriers can improve the delivery of localized radiation to tumors. Nanoparticles labeled with certain beta-emitting radionuclides are intrinsically theranostic agents that can provide information regarding distribution and regional dosimetry within the tumor and the body. Image-guided thermal therapy results in increased uptake of intravenous nanoparticles within tumors, improving therapy. In addition, nanoparticles are ideal carriers for direct intratumoral infusion of beta-emitting radionuclides by convection enhanced delivery, permitting the delivery of localized therapeutic radiation without the requirement of the radionuclide exiting from the nanoparticle. With this approach, very high doses of radiation can be delivered to solid tumors while sparing normal organs. Recent technological developments in image-guidance, convection enhanced delivery and newly developed nanoparticles carrying beta-emitting radionuclides will be reviewed. Examples will be shown describing how this new approach has promise for the treatment of brain, head and neck, and other types of solid tumors.
AB - One of the major limitations of current cancer therapy is the inability to deliver tumoricidal agents throughout the entire tumor mass using traditional intravenous administration. Nanoparticles carrying beta-emitting therapeutic radionuclides that are delivered using advanced image-guidance have significant potential to improve solid tumor therapy. The use of image-guidance in combination with nanoparticle carriers can improve the delivery of localized radiation to tumors. Nanoparticles labeled with certain beta-emitting radionuclides are intrinsically theranostic agents that can provide information regarding distribution and regional dosimetry within the tumor and the body. Image-guided thermal therapy results in increased uptake of intravenous nanoparticles within tumors, improving therapy. In addition, nanoparticles are ideal carriers for direct intratumoral infusion of beta-emitting radionuclides by convection enhanced delivery, permitting the delivery of localized therapeutic radiation without the requirement of the radionuclide exiting from the nanoparticle. With this approach, very high doses of radiation can be delivered to solid tumors while sparing normal organs. Recent technological developments in image-guidance, convection enhanced delivery and newly developed nanoparticles carrying beta-emitting radionuclides will be reviewed. Examples will be shown describing how this new approach has promise for the treatment of brain, head and neck, and other types of solid tumors.
KW - Beta-emitting radionuclides
KW - Convection enhanced delivery
KW - Drug delivery
KW - Imaging
KW - Liposomes
KW - Radionuclide therapy
KW - Rhenium-186
KW - Solid tumor
UR - http://www.scopus.com/inward/record.url?scp=84928211140&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84928211140&partnerID=8YFLogxK
U2 - 10.1016/j.addr.2014.07.001
DO - 10.1016/j.addr.2014.07.001
M3 - Review article
C2 - 25016083
AN - SCOPUS:84928211140
SN - 0169-409X
VL - 76
SP - 39
EP - 59
JO - Advanced Drug Delivery Reviews
JF - Advanced Drug Delivery Reviews
IS - 1
ER -